Acute Therapies

Acute Therapies Portfolio flex Baxter s Continuous Renal Replacement Therapy Prismaflex 17k+ CRRT Monitors Installed L KERA Regiocit/Региоцит Pasl phoxilium BANG CRRT Fluids Customized for Patient Needs 92% $456M 2017 Sales 8% oXiris S First 3-in-1 Sepsis Management Filter TPE 1000/2000 Therapeutic Plasma Exchange Organ Support Therapies Leading Product Portfolio To Meet Market Needs | 5

View entire presentation